Enlighten: An Adaptive Technology Weight Loss Intervention
2013年9月20日 更新者：Bonnie Spring、Northwestern University
The Enlighten study is an 8-week trial investigating the response to use of a smartphone diet and activity application.
Participants are enrolled as part of a worksite intervention, and will receive the LoseIt!
weight loss smartphone application, which requires participants to self-monitor dietary intake and physical activity, a component shown to effectively produce weight loss.
The application will be programmed to deliver dietary intake recommendations during the first three weeks of the intervention.
At the 3 week time point, self-monitoring adherence via the smartphone application will be assessed and those who are not responding will receive 4 weekly telephone coaching sessions.
Those individuals who respond at the end of 3 weeks will be encouraged to continue self-monitoring on the application.
All participants will also receive regular text messages throughout the trial.
The importance of the proposed research lies in the objective to reconfigure weight loss treatment so as to achieve the intended outcome more efficiently and in a manner that allows greater reach.
研究概览
研究类型
介入性
注册 (预期的)
10
阶段
- 不适用
联系人和位置
本节提供了进行研究的人员的详细联系信息，以及有关进行该研究的地点的信息。
学习地点
-
-
Illinois
-
Chicago、Illinois、美国、60611
- Northwestern University
-
-
参与标准
研究人员寻找符合特定描述的人，称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
18年 至 60年 (成人)
接受健康志愿者
不
有资格学习的性别
全部
描述
Inclusion Criteria:
- BMI greater than 25-39.9 kg/m2
- Weigh no more than 300 pounds.
- Weight stable (no loss or gain >25 lbs for the past 6 months)
- Not enrolled in any formal weight loss program
- Not currently taking anti-obesity medications
- Interested in losing weight
- Own an Android Smartphone or iPhone, be willing to install the Lose It! Application, and agree to join the Enlighten group which will allow study staff to view participant data using a private coaching interface.
Exclusion Criteria:
- Unstable medical conditions (uncontrolled hypertension, diabetes, unstable angina pectoris, myocardial infarction, transient ischemic attack, cancer undergoing active treatment, or cerebrovascular accident within the past six months)
- History of diabetes requiring insulin supplementation
- Crohn's Disease
- Diagnosis of obstructive sleep apnea requiring intervention (i.e. CPAP)
- Require use of an assistive device for mobility (e.g., wheelchair, walker, cane)
- BMI greater than or equal to 40, weight greater than or equal to 300 pounds
- Hospitalization for a psychiatric disorder within the past 5 years
- Those at risk for adverse cardiovascular (CVD) events with moderate intensity activity
- Those who cannot read the study questionnaires will be excluded
- Those currently taking weight loss medication or committed to following an incompatible dietary regimen.
- Female participants may not be pregnant, trying to get pregnant, or lactating.
- Bulimia Nervosa
- Binge Eating Disorder
- Active Suicidal Ideation
- those on medications known to cause weight gain (e.g., prednisone)
- current substance abuse or dependence besides nicotine dependence
- low motivation to change that would interfere with program adherence
学习计划
本节提供研究计划的详细信息，包括研究的设计方式和研究的衡量标准。
研究是如何设计的？
设计细节
- 主要用途：治疗
- 分配：不适用
- 介入模型：单组作业
- 屏蔽：单身的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的：Technology Supported
|
All participants will complete 8 weeks of recording of dietary intake, weight, and physical activity on a smartphone application.
Time-stamped data from the smartphone will upload automatically to the application server, where it will be visible to the lifestyle coach.
The participant's real-time diet, activity and weight data relative to their goals will be visually depicted on the participant's smartphone.
The coach will monitor participant adherence and send supportive text messages.
Response to the application will be assessed 3 weeks after enrollment into the study; measured by number of food items recorded between weeks 1-3 of the intervention; an indicator of use and adherence.
Based on adherence, some participants may receive 4 telephone coaching sessions between weeks 5 and 8. Telephone coaching sessions will include feedback on self-monitoring and goal attainment, problem solving, and motivational interviewing.
|
研究衡量的是什么？
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change in Anthropometric Measures
大体时间：Baseline, 8 Weeks
|
Weight, Waist Circumference, Blood Pressure
|
Baseline, 8 Weeks
|
|
Self-Monitoring Adherence over Time
大体时间：Baseline, 8 weeks
|
Diet,Activity & Weight Self-Monitoring
|
Baseline, 8 weeks
|
次要结果测量
结果测量 |
大体时间 |
|---|---|
|
人口统计
大体时间：基线
|
基线
|
|
Call Session Adherence
大体时间：8 weeks
|
8 weeks
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
调查人员
- 首席研究员：Bonnie J Spring, PhD、Northwestern University
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查，以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始
2013年5月1日
初级完成 (实际的)
2013年9月1日
研究完成 (实际的)
2013年9月1日
研究注册日期
首次提交
2013年5月10日
首先提交符合 QC 标准的
2013年5月14日
首次发布 (估计)
2013年5月17日
研究记录更新
最后更新发布 (估计)
2013年9月24日
上次提交的符合 QC 标准的更新
2013年9月20日
最后验证
2013年9月1日
更多信息
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.
Technology Supported的临床试验
-
MicroPort Orthopedics Inc.完全的
-
Arash Asher, MDVoxxLife招聘中
-
Zimmer Biomet招聘中
-
Medtronic Neurovascular Clinical AffairsMedtronic Bakken Research Center完全的颅内动脉瘤英国, 丹麦, 以色列, 法国, 西班牙, 德国, 希腊, 澳大利亚, 芬兰, 匈牙利, 意大利
-
Medtronic Neurovascular Clinical Affairs主动，不招人